Skip to menu Skip to content Skip to footer

2023

Journal Article

Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer

Gough, Madeline, Liu, Cheng, Srinivasan, Bhuvana, Wilkinson, Lisa, Dunk, Louisa, Yang, Yuanhao, Schreiber, Veronika, Tuffaha, Haitham, Kryza, Thomas, Hooper, John D., Lakhani, Sunil R. and Snell, Cameron E. (2023). Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer. Histopathology, 83 (4), 647-656. doi: 10.1111/his.15000

Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer

2023

Journal Article

Design live loads for office gathering spaces

Corotis, Ross B., Hooper, John D. and Klemencic, Ronald (2023). Design live loads for office gathering spaces. Journal of Structural Engineering, 149 (12) 04023170, 1-11. doi: 10.1061/JSENDH.STENG-12518

Design live loads for office gathering spaces

2023

Journal Article

MUC13 cell surface mucin limits Salmonella Typhimurium infection by protecting the mucosal epithelial barrier

McGuckin, Michael A., Davies, Julie M., Felgner, Pascal, Wong, Kuan Yau, Giri, Rabina, He, Yaowu, Moniruzzaman, Md., Kryza, Thomas, Sajiir, Haressh, Hooper, John D., Florin, Timothy H., Begun, Jakob, Oussalah, Abderrahim, Hasnain, Sumaira Z., Hensel, Michael and Sheng, Yong H. (2023). MUC13 cell surface mucin limits Salmonella Typhimurium infection by protecting the mucosal epithelial barrier. Cellular and Molecular Gastroenterology and Hepatology, 16 (6), 985-1009. doi: 10.1016/j.jcmgh.2023.08.011

MUC13 cell surface mucin limits Salmonella Typhimurium infection by protecting the mucosal epithelial barrier

2023

Journal Article

The roles of proteases in prostate cancer

Koistinen, Hannu, Kovanen, Ruusu‐Maaria, Hollenberg, Morley D., Dufour, Antoine, Radisky, Evette S., Stenman, Ulf‐Håkan, Batra, Jyotsna, Clements, Judith, Hooper, John D., Diamandis, Eleftherios, Schilling, Oliver, Rannikko, Antti and Mirtti, Tuomas (2023). The roles of proteases in prostate cancer. IUBMB Life, 75 (6), 493-513. doi: 10.1002/iub.2700

The roles of proteases in prostate cancer

2023

Journal Article

Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer

Dutt, Mriga, Hartel, Gunter, Richards, Renee S., Shah, Alok K., Mohamed, Ahmed, Apostolidou, Sophia, Gentry‐Maharaj, Aleksandra, Hooper, John D., Perrin, Lewis C., Menon, Usha, Hill, Michelle M. and Australian Ovarian Cancer Study Group (2023). Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer. Proteomics - Clinical Applications, 17 (4) 2200114, 1-16. doi: 10.1002/prca.202200114

Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer

2023

Journal Article

Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma

Raninga, Prahlad V., He, Yaowu, Datta, Keshava K., Lu, Xue, Maheshwari, Uma R., Venkat, Pooja, Mayoh, Chelsea, Gowda, Harsha, Kalimutho, Murugan, Hooper, John D. and Khanna, Kum Kum (2023). Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma. Molecular Therapy, 31 (3) 212011, 729-743. doi: 10.1016/j.ymthe.2022.12.011

Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma

2023

Journal Article

Reactive oxygen species as mediators of disease progression and therapeutic response in colorectal cancer

Lyons, Nicholas, Giri, Rabina, Begun, Jakob, Clark, David A, Proud, David, He, Yaowu, Hooper, John and Kryza, Thomas (2023). Reactive oxygen species as mediators of disease progression and therapeutic response in colorectal cancer. Antioxidants and Redox Signaling, 39 (1-3), 186-205. doi: 10.1089/ars.2022.0127

Reactive oxygen species as mediators of disease progression and therapeutic response in colorectal cancer

2023

Journal Article

Missing parameters in malignant polyp histology reports: can appropriate decisions be made?

Zammit, Andrew P., Brown, Ian, Hooper, John D., Clark, David A. and Riddell, Andrew D. (2023). Missing parameters in malignant polyp histology reports: can appropriate decisions be made?. Pathology, 55 (1), 58-63. doi: 10.1016/j.pathol.2022.06.007

Missing parameters in malignant polyp histology reports: can appropriate decisions be made?

2023

Journal Article

In comparison with polypectomy, colorectal resection is associated with improved survival for patients diagnosed with malignant polyps

Zammit, Andrew P., Hooper, John D., Brown, Ian, Clark, David A. and Riddell, Andrew D. (2023). In comparison with polypectomy, colorectal resection is associated with improved survival for patients diagnosed with malignant polyps. Colorectal Disease, 25 (2), 261-271. doi: 10.1111/codi.16369

In comparison with polypectomy, colorectal resection is associated with improved survival for patients diagnosed with malignant polyps

2023

Journal Article

Malignant polyps in the COVID ‐19 era: a population‐based analysis

Zammit, Andrew P., Brown, Ian, Hooper, John D., Clark, David A. and Riddell, Andrew D. (2023). Malignant polyps in the COVID ‐19 era: a population‐based analysis. ANZ Journal of Surgery, 93 (4), 932-938. doi: 10.1111/ans.18253

Malignant polyps in the COVID ‐19 era: a population‐based analysis

2023

Journal Article

Management of high and low risk malignant polyps – a population wide analysis

Zammit, Andrew P., Panahi, Seyed E., Brown, Ian, Hooper, John D., Clark, David A. and Riddell, Andrew D. (2023). Management of high and low risk malignant polyps – a population wide analysis. Colorectal Disease, 25 (1), 66-74. doi: 10.1111/codi.16328

Management of high and low risk malignant polyps – a population wide analysis

2022

Journal Article

CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors

Lu, Xue, He, Yaowu, Johnston, Rebecca L., Nanayakarra, Devathri, Sankarasubramanian, Sivanandhini, Lopez, J. Alejandro, Friedlander, Michael, Kalimutho, Murugan, Hooper, John D., Raninga, Prahlad V. and Khanna, Kum Kum (2022). CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors. Journal of Experimental and Clinical Cancer Research, 41 (1) 355, 1-17. doi: 10.1186/s13046-022-02570-4

CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors

2022

Journal Article

Timing of surveillance colonoscopy following malignant colorectal polypectomy in Queensland

Zammit, Andrew P., Brown, Ian, Hooper, John D., Clark, David A. and Riddell, Andrew D. (2022). Timing of surveillance colonoscopy following malignant colorectal polypectomy in Queensland. ANZ Journal of Surgery, 93 (3), 606-611. doi: 10.1111/ans.18069

Timing of surveillance colonoscopy following malignant colorectal polypectomy in Queensland

2022

Journal Article

CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy

Khan, Tashbib, Lyons, Nicholas J., Gough, Madeline, Kwah, Kayden K.X., Cuda, Tahleesa J., Snell, Cameron E., Tse, Brian W., Sokolowski, Kamil A., Pearce, Lesley A., Adams, Timothy E., Rose, Stephen E., Puttick, Simon, Pajic, Marina, Adams, Mark N., He, Yaowu, Hooper, John D. and Kryza, Thomas (2022). CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy. Theranostics, 12 (16), 6915-6930. doi: 10.7150/thno.78171

CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy

2022

Journal Article

A population‐based study of the management of rectal malignant polyps and the use of trans‐anal surgery

Zammit, Andrew P., Brown, Ian, Hooper, John D., Clark, David A. and Riddell, Andrew D. (2022). A population‐based study of the management of rectal malignant polyps and the use of trans‐anal surgery. ANZ Journal of Surgery, 92 (11), 2949-2955. doi: 10.1111/ans.17917

A population‐based study of the management of rectal malignant polyps and the use of trans‐anal surgery

2022

Journal Article

Erratum: Alpha-Tomatine Attenuation of In Vivo Growth of Subcutaneous and Orthotopic Xenograft Tumors of Human Prostate Carcinoma PC-3 Cells Is Accompanied by Inactivation of Nuclear Factor-Kappa B Signaling (PLoS ONE (2013) 8:2 (e57708) DOI: 10.1371/journal.pone.0057708)

Lee, Sui-Ting, Wong, Pooi-Fong, He, Hui, Hooper, John David and Mustafa, Mohd Rais (2022). Erratum: Alpha-Tomatine Attenuation of In Vivo Growth of Subcutaneous and Orthotopic Xenograft Tumors of Human Prostate Carcinoma PC-3 Cells Is Accompanied by Inactivation of Nuclear Factor-Kappa B Signaling (PLoS ONE (2013) 8:2 (e57708) DOI: 10.1371/journal.pone.0057708). PLoS ONE, 17 (5 May) e0268234. doi: 10.1371/journal.pone.0268234

Erratum: Alpha-Tomatine Attenuation of In Vivo Growth of Subcutaneous and Orthotopic Xenograft Tumors of Human Prostate Carcinoma PC-3 Cells Is Accompanied by Inactivation of Nuclear Factor-Kappa B Signaling (PLoS ONE (2013) 8:2 (e57708) DOI: 10.1371/journal.pone.0057708)

2022

Journal Article

Protease‐activated receptor‐2 dependent and independent responses of bone cells to prostate cancer cell secretory products

Pagel, Charles N., Kularathna, Pamu K., Sanaei, Reza, Young, Neil D., Hooper, John D. and Mackie, Eleanor J. (2022). Protease‐activated receptor‐2 dependent and independent responses of bone cells to prostate cancer cell secretory products. The Prostate, 82 (6), 723-739. doi: 10.1002/pros.24316

Protease‐activated receptor‐2 dependent and independent responses of bone cells to prostate cancer cell secretory products

2022

Journal Article

Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis

Zammit, Andrew P., Lyons, Nicholas J., Chatfield, Mark D., Hooper, John D., Brown, Ian, Clark, David A. and Riddell, Andrew D. (2022). Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis. International Journal of Colorectal Disease, 37 (5), 1035-1047. doi: 10.1007/s00384-022-04142-6

Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis

2022

Journal Article

Toward functional recovery performance in the seismic design of modern tall buildings

Hutt, Carlos Molina, Hulsey, Anne M., Kakoty, Preetish, Deierlein, Greg G., Monfared, Alireza Eksir, Yen Wen-Yi, and Hooper, John D. (2022). Toward functional recovery performance in the seismic design of modern tall buildings. Earthquake Spectra, 38 (1), 283-309. doi: 10.1177/87552930211033620

Toward functional recovery performance in the seismic design of modern tall buildings

2021

Journal Article

Protease-activated receptor-2 promotes osteogenesis in skeletal mesenchymal stem cells at the expense of adipogenesis: involvement of interleukin-6

Sanaei, R., Kularathna, P. K., Taghavi, N., Hooper, J. D., Pagel, C. N. and Mackie, E. J. (2021). Protease-activated receptor-2 promotes osteogenesis in skeletal mesenchymal stem cells at the expense of adipogenesis: involvement of interleukin-6. Bone Reports, 15 101113, 101113. doi: 10.1016/j.bonr.2021.101113

Protease-activated receptor-2 promotes osteogenesis in skeletal mesenchymal stem cells at the expense of adipogenesis: involvement of interleukin-6